Liver Cancer Cell Lines
Database

LCCL to predict drug response

Drug: Sorafenib_Trametinib

DrugsAliasTargetsTargeted cellular functionClinical status in any tumor typeClinical status in HCCSupplierReference
Sorafenib_Trametinib BRAF, KDR, FLT4, PDGFRB, KIT, FLT3, RET and MEK1/2 Drug combination Selleck Chemicals S1040, S2673

Cell Line (34)
Cell LineAUCGI50
SNU878
B10.30.02
JHH50.350.01
HepaRG0.350.02
HepG20.370.001
HCC.1.20.410.03
JHH10.420.01
SNU8860.430.04
SNU3870.520.1
Hep3B0.590.08
JHH20.610.16
SNU7610.620.12
SNU3980.692.18
HCC.30.692.22
Huh60.71.49


LCCL transcriptomic subgroup:
CL1
CL2
CL3
undef.

Codebase Soc. Coop.
info@codebase.it